This online competency assessment is for the classification of BRCA1 and BRCA2 gene variants related to ovarian cancer, and BRCA2 variants related to prostate cancer, and their predicted response to PARP inhibitor treatment.  

This assessment is open to all individuals who classify the pathogenicity of BRCA variants.
This is an additional online educational tool for our participants. It is separate from the BRCA testing in Ovarian cancer EQAs scheme and does not replace them.

The Process of Participation
  • All participants will receive full instructions and key dates via email.
  • Secure website access to G-TACT will be provided.
  • Participants submit their classification and evidence for fifteen BRCA1/BRCA2 variants.
  • Please use ACMG Variant Classification guidelines (Richards et al. 2015).
  • You can participant for BRCA variants associated with ovarian cancer and/or prostate cancer.
  • Your participation in this assessment and your individual data, remain confidential between yourself and EMQN/GenQA.

Benefits of Participation

On completion of the this educational scheme all participants will receive the following:
  • An individual report summarising their classification.
  • A summary report to enable benchmarking against the expert predicted classifications.
  • An invitation to access the variant classification videos with explanations and evidence used for the expert predicted classifications.
  • A certificate of participation.
A subsequent presentation (eg.WebEx)  will be held to answer any questions and provide educational support.

How to participate in the 2020 scheme

Registration is now open and easy to complete.
  • Please complete this form to register for this assessment.
  • All information including key dates and full instructions on how to complete the assessment will be sent to you.
  • There is no fee to participate as Astra Zeneca has provided a grant to fund all participation costs.Please note that Astra Zeneca will not be provided with your identified assessment results.
  • The closing date for registrations is 18th August 2020.